Astellas to Nominate Two Directors to CV Therapeutics Board
Astellas’s hostile bid takes a new turn as the Japanese company tries to oust remaining CVT board
members and replace them with their own.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
Categories: Top Pharmaceutical companies
